Increase in oral cancer drugs raises thorny issues for oncology practices.

Journal of the National Cancer Institute

Volumn 101, Issue 22, 2009, Pages 1534-1536

  Hede, Karyn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CLINICAL PRACTICE; ECONOMICS; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED MEDICINE; HUMAN; INSURANCE; INTERNATIONAL COOPERATION; INTRAVENOUS DRUG ADMINISTRATION; LEGAL ASPECT; MEDICARE; MEDICATION ERROR; MOUTH TUMOR; NOTE; ORAL DRUG ADMINISTRATION; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; STANDARD; UNITED STATES;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; INDIANA; INFUSIONS, INTRAVENOUS; INSURANCE COVERAGE; INTERNATIONAL COOPERATION; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MEDICARE; MEDICATION ADHERENCE; MEDICATION ERRORS; MOUTH NEOPLASMS; OREGON; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 79955037760     PISSN: None     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp421     Document Type: Note

References (0)